Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.72 is 55% below its 5-year average of 12.62, near the low end of its 5-year range (5.72–23.26).
As of the fiscal period ended Tuesday, June 30, 2026. 30.31% below its 12-month average of 8.21.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.72.
QUICK RATIO (ACID-TEST)
5.72
QUICK RATIO (ACID-TEST) AVG TTM
8.21
QUICK RATIO (ACID-TEST) AVG 3Y
13.01
QUICK RATIO (ACID-TEST) AVG 5Y
12.62
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-30.31%
CURRENT VS 3Y AVG
-56.01%
CURRENT VS 5Y AVG
-54.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+70.60%
vs the sector median at left
Vaxcyte, Inc.
Market Cap
$9.63B
Quick Ratio (Acid-Test)
5.72
TTM Avg
8.21
3Y Avg
13.01
5Y Avg
12.62
Market Cap
$9.63B
Quick Ratio (Acid-Test)
7.96
TTM Avg
8.29
3Y Avg
11.86
5Y Avg
13.73
Market Cap
$9.66B
Quick Ratio (Acid-Test)
0.73
TTM Avg
0.77
3Y Avg
0.86
5Y Avg
0.88
Market Cap
$9.87B
Quick Ratio (Acid-Test)
7.64
TTM Avg
7.20
3Y Avg
5.45
5Y Avg
4.39
Market Cap
$9.93B
Quick Ratio (Acid-Test)
2.33
TTM Avg
4.52
3Y Avg
4.42
5Y Avg
3.69
Market Cap
$10.03B
Quick Ratio (Acid-Test)
1.21
TTM Avg
1.49
3Y Avg
1.44
5Y Avg
1.33
Market Cap
$9.21B
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.82
3Y Avg
1.02
5Y Avg
1.25
Market Cap
$10.13B
Quick Ratio (Acid-Test)
1.28
TTM Avg
1.17
3Y Avg
1.11
5Y Avg
1.16
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.63B | 5.72 | 8.21 | 13.01 | 12.62 |
| Krystal Biotech, Inc. (KRYS)vs › | $9.63B | 7.96 | 8.29 | 11.86 | 13.73 |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 0.73 | 0.77 | 0.86 | 0.88 |
| Repligen Corporation (RGEN)vs › | $9.87B | 7.64 | 7.20 | 5.45 | 4.39 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 2.33 | 4.52 | 4.42 | 3.69 |
| Insulet Corp. (PODD)vs › | $9.33B | 1.83 | 2.42 | 2.51 | 3.28 |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 1.21 | 1.49 | 1.44 | 1.33 |
| Bruker Corporation (BRKR)vs › | $9.21B | 0.92 | 0.82 | 1.02 | 1.25 |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 1.28 | 1.17 | 1.11 | 1.16 |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | 5.70 | 4.14 | 3.40 | 2.70 |
Quick Ratio
5.72
Excludes inventory
Current Ratio
5.72
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.72 |
| 2026-03-31 | 7.49 |
| 2025-12-31 | 7.91 |
| 2025-09-30 | 8.83 |
| 2025-06-30 | 11.11 |
| 2025-03-31 | 17.70 |
| 2024-12-31 | 12.75 |
| 2024-09-30 | 17.88 |
| 2024-06-30 | 17.88 |
| 2024-03-31 | 17.42 |
| 2023-12-31 | 7.54 |
| 2023-09-30 | 15.14 |
| 2023-06-30 | 21.76 |
| 2023-03-31 | 15.94 |
| 2022-12-31 | 23.26 |
| 2022-09-30 | 9.41 |
| 2022-06-30 | 11.94 |
| 2022-03-31 | 12.56 |
| 2021-12-31 | 8.93 |
| 2021-09-30 | 6.38 |
| 2021-06-30 | 7.41 |
| 2021-03-31 | 5.90 |
| 2020-12-31 | 8.30 |
| 2020-09-30 | 10.12 |
| 2020-06-30 | 12.56 |
| 2020-03-31 | 6.47 |
| 2019-12-31 | 5.58 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
